☆ 4.7 Article

Post-infection treatment with the E protein inhibitor BIT225 reduces disease severity and increases survival of K18-hACE2 transgenic mice infected with a lethal dose of SARS-CoV-2

PLOS PATHOGENS (2023)

Related references

Note: Only part of the references are listed.

Article Genetics & Heredity

Role of genomics in combating COVID-19 pandemic

K. A. Saravanan et al.

Summary: The advancements in genomics have played a significant role in the scientific understanding and public health response to the COVID-19 pandemic. Genomic technologies have been utilized to better understand the characteristics and origins of the novel coronavirus, leading to the development of vaccines.

GENE (2022)

Add to Collection

Review Immunology

Basic virology of SARS-CoV 2

V. Ravi et al.

Summary: This review focuses on the basic virology of SARS CoV-2, including its origin, structure, genomic characteristics, pathogenesis, immunological response, and clinical manifestation, as well as the key differences from previous coronaviruses.

INDIAN JOURNAL OF MEDICAL MICROBIOLOGY (2022)

Add to Collection

Review Microbiology

Molecular Virology of SARS-CoV-2 and Related Coronaviruses

Yu-An Kung et al.

Summary: This review discusses the molecular mechanisms of SARS-CoV-2 and related coronaviruses, with a focus on host factors or pathways identified through genome-wide CRISPR screening that can be targeted for the development of effective antiviral agents.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2022)

Add to Collection

Article Multidisciplinary Sciences

Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19

Lok-Yin Roy Wong et al.

Summary: This article describes the research on therapeutic drugs against new variants of SARS-CoV-2. The study suggests that the elderly population is at higher risk during infection, and protecting aged animals from severe diseases can be achieved by inhibiting specific inflammatory pathways.

NATURE (2022)

Add to Collection

Article Pharmacology & Pharmacy

Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice

Ju Hwan Jeong et al.

Summary: Combination therapy with nirmatrelvir and molnupiravir significantly inhibits SARS-CoV-2 replication, improves survival rates, and alleviates clinical severity and virus-induced tissue damage.

ANTIVIRAL RESEARCH (2022)

Add to Collection

Article Immunology

Human Immunodeficiency Virus Type 1 Vpu Inhibitor, BIT225, in Combination with 3-Drug Antiretroviral Therapy: Inflammation and Immune Cell Modulation

Carolyn A. Luscombe et al.

Summary: BIT225, a first-in-class inhibitor of HIV-1 Vpu, was found to be safe and well tolerated in combination with standard ART in a clinical trial conducted in Thailand. The treatment was shown to have comparable antiviral efficacy to ART alone, with potential modulation of inflammatory and immune function noted in patients treated with BIT225. Further clinical studies are planned to confirm and expand on these findings in both treatment-naive and treatment-experienced individuals.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Review Microbiology

Characteristics of SARS-CoV-2 and COVID-19

Ben Hu et al.

Summary: This review summarizes the research progress on SARS-CoV-2 and COVID-19, including virology characteristics, pathogenesis, and recent advances in treatment methods. Furthermore, it discusses in detail the potential wildlife hosts and zoonotic origin of this emerging virus.

NATURE REVIEWS MICROBIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801

Angela Wahl et al.

Summary: The study suggests that bats may be the source of coronaviruses that can be directly transmitted to humans. Using the LoM model, efficient replication of SARS-CoV, MERS-CoV, SARS-CoV-2, and two SARS-like bat coronaviruses in human lung tissue was demonstrated. Infection with SARS-CoV-2 predominantly targets human lung epithelial cells and induces a sustained inflammatory response. The broad-spectrum antiviral agent EIDD-2801 significantly inhibits SARS-CoV-2 replication in vivo, showing potential for prevention and treatment of COVID-19.

NATURE (2021)

Add to Collection

Review Virology

Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease

Siobhan Gargan et al.

Summary: Viroporins are a family of important viral proteins that regulate viral infection and replication in host cells, as well as contribute to viral immune evasion. Studies on viroporins are essential for the development of novel antiviral therapies.

VIRUSES-BASEL (2021)

Add to Collection

Article Multidisciplinary Sciences

Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein

Mustafa Yalcinkaya et al.

Summary: Although some drugs and vaccines targeting COVID-19 have shown initial success, understanding the underlying disease pathogenesis of SARS-CoV-2 is crucial for further treatment development. Research indicates that the SARS-CoV-2 envelope protein may initially suppress the host NLRP3 inflammasome response to viral RNA, but potentially increase inflammasome responses in later stages of infection. Targeting the SARS-CoV-2 E protein, especially in early infection stages, could be a novel approach to COVID-19 therapy.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Pharmacology & Pharmacy

Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro

Jeremy R. A. Paull et al.

Summary: The study showed that astodrimer sodium has inhibitory effects on the replication of SARS-CoV-2 and can effectively deactivate the virus, indicating its potential as a topically administered agent for therapeutic applications against COVID-19.

ANTIVIRAL RESEARCH (2021)

Add to Collection

Article Cell Biology

SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target

Bingqing Xia et al.

Summary: The study demonstrated that the SARS-CoV-2 protein 2-E alone can cause acute respiratory distress syndrome (ARDS)-like damage and induce rapid cell death and cytokine release. Inhibiting the 2-E channel can effectively reduce the viral load and secretion of inflammation cytokines in the lungs, making it a promising drug target against SARS-CoV-2.

CELL RESEARCH (2021)

Add to Collection

Article Multidisciplinary Sciences

Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection

Chamandi S. Dampalla et al.

Summary: The study presents a series of deuterated 3CLpro inhibitor variants, particularly GC376, showing potent antiviral effects against SARS-CoV-2 in cell-based and enzyme assays. Treatment with a deuterated derivative of GC376 increased survival rates in lethally infected mice and reduced lung virus titers and histopathological changes. Structural investigation revealed promising potential of deuterated GC376 variants as effective antiviral agents against SARS-CoV-2 through their binding interactions with 3CLpro.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Add to Collection

Article

The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target

Lobna Al-Zaidan et al.

TUMOR BIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice

Jian Zheng et al.

Summary: The COVID-19 pandemic is associated with significant morbidity and mortality. Experimental studies in animals infected with SARS-CoV-2 have revealed severe lung and brain damage, as well as early onset anosmia in mice. Excitingly, infusion of convalescent plasma from recovered patients has shown to protect against lethal disease, though it does not prevent anosmia.

NATURE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Viroporins and inflammasomes: A key to understand virus-induced inflammation

N. S. Farag et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2020)

Add to Collection

Article Cell Biology

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Timothy P. Sheahan et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Immunology

Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19

Adnan Shah

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Review Multidisciplinary Sciences

Animal models for COVID-19

Cesar Munoz-Fontela et al.

NATURE (2020)

Add to Collection

Article Immunology

SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function

Emma S. Winkler et al.

NATURE IMMUNOLOGY (2020)

Add to Collection

Editorial Material Medicine, General & Internal

Virology, transmission, and pathogenesis of SARS-CoV-2

Muge Cevik et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Article Medicine, Research & Experimental

Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease

Joseph W. Golden et al.

JCI INSIGHT (2020)

Add to Collection

Article Multidisciplinary Sciences

Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice

Fatai S. Oladunni et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers

Venkata S. Mandala et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)

Add to Collection

Article Microbiology

Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome

I-Yin Chen et al.

FRONTIERS IN MICROBIOLOGY (2019)

Add to Collection

Article Microbiology

Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis

Carlos Castano-Rodriguez et al.

MBIO (2018)

Add to Collection

Article Multidisciplinary Sciences

Organelle luminal dependence of (+)strand RNA virus replication reveals a hidden druggable target

Masaki Nishikiori et al.

SCIENCE ADVANCES (2018)

Add to Collection

Article Cell Biology

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Timothy P. Sheahan et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Add to Collection

Article Infectious Diseases

A Phase 1b/2a study of the safety, pharmacokinetics and antiviral activity of BIT225 in patients with HIV-1 infection

John Wilkinson et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)

Add to Collection

Article Infectious Diseases

The antiviral compound BIT225 inhibits HIV-1 replication in myeloid dendritic cells

Gabriela Khoury et al.

AIDS RESEARCH AND THERAPY (2016)

Add to Collection

Article Virology

Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome

Jose L. Nieto-Torres et al.

VIROLOGY (2015)

Add to Collection

Review Virology

Relevance of Viroporin Ion Channel Activity on Viral Replication and Pathogenesis

Jose L. Nieto-Torres et al.

VIRUSES-BASEL (2015)

Add to Collection

Article Multidisciplinary Sciences

Dose-Response Analysis Using R

Christian Ritz et al.

PLOS ONE (2015)

Add to Collection

Article Microbiology

Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis

Jose L. Nieto-Torres et al.

PLOS PATHOGENS (2014)

Add to Collection

Review Biochemistry & Molecular Biology

Viroporins Customize Host Cells for Efficient Viral Propagation

Kristina M. Giorda et al.

DNA AND CELL BIOLOGY (2013)

Add to Collection

Review Microbiology

Viroporins: structure and biological functions

Jose Luis Nieva et al.

NATURE REVIEWS MICROBIOLOGY (2012)

Add to Collection

Article Biochemical Research Methods

Ligand-protein docking studies of potential HIV-1 drug compounds using the algorithm FlexX

George Patargias et al.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)

Add to Collection

Article Microbiology

Antiviral Efficacy of the Novel Compound BIT225 against HIV-1 Release from Human Macrophages

Gabriela Khoury et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)

Add to Collection

Article Pharmacology & Pharmacy

A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-α-2b and nucleoside analogues

Carolyn A. Luscombe et al.

ANTIVIRAL RESEARCH (2010)

Add to Collection

Article Virology

Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2

Jason Netland et al.

JOURNAL OF VIROLOGY (2008)

Add to Collection

Article Virology

Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus

Paul B. McCray et al.

JOURNAL OF VIROLOGY (2007)

Add to Collection

Article Virology

Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication

Lauren Wilson et al.

VIROLOGY (2006)

Add to Collection

Article Virology

SARS coronavirus E protein forms cation-selective ion channels

L Wilson et al.

VIROLOGY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.